A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 271,023 shares of GILD stock, worth $24.4 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
271,023
Previous 273,653 0.96%
Holding current value
$24.4 Million
Previous $18.8 Million 21.0%
% of portfolio
0.15%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$66.59 - $83.99 $175,131 - $220,893
-2,630 Reduced 0.96%
271,023 $22.7 Million
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $7,578 - $8,745
120 Added 0.04%
273,653 $18.8 Million
Q1 2024

May 08, 2024

BUY
$71.58 - $87.29 $47,672 - $58,135
666 Added 0.24%
273,533 $20 Million
Q4 2023

Feb 09, 2024

BUY
$73.27 - $83.09 $1.64 Million - $1.86 Million
22,334 Added 8.91%
272,867 $22.1 Million
Q3 2023

Nov 09, 2023

BUY
$73.94 - $80.67 $2.44 Million - $2.66 Million
32,990 Added 15.16%
250,533 $18.8 Million
Q2 2023

Aug 09, 2023

BUY
$76.01 - $86.7 $467,157 - $532,858
6,146 Added 2.91%
217,543 $16.8 Million
Q1 2023

May 09, 2023

SELL
$77.31 - $88.08 $47,391 - $53,993
-613 Reduced 0.29%
211,397 $17.5 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $1.79 Million - $2.57 Million
28,681 Added 15.64%
212,010 $18.2 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $41,737 - $47,675
701 Added 0.38%
183,329 $11.3 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $853,563 - $961,367
14,788 Added 8.81%
182,628 $11.3 Million
Q1 2022

May 12, 2022

BUY
$57.92 - $72.58 $601,962 - $754,323
10,393 Added 6.6%
167,840 $9.98 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $21,021 - $23,859
324 Added 0.21%
157,447 $11.4 Million
Q3 2021

Nov 10, 2021

SELL
$67.69 - $73.03 $812 - $876
-12 Reduced 0.01%
157,123 $11 Million
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $1,523 - $1,664
-24 Reduced 0.02%
157,135 $10.8 Million
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $31,680 - $36,146
528 Added 0.34%
157,159 $10.2 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $2.29 Million - $2.61 Million
40,468 Added 34.84%
156,631 $9.13 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $2.76 Million - $3.47 Million
44,458 Added 62.0%
116,163 $7.34 Million
Q2 2020

Aug 11, 2020

SELL
$72.34 - $84.0 $659,885 - $766,248
-9,122 Reduced 11.29%
71,705 $5.52 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $40,333 - $51,661
-644 Reduced 0.79%
80,827 $6.04 Million
Q4 2019

Feb 11, 2020

BUY
$61.62 - $67.78 $19,533 - $21,486
317 Added 0.39%
81,471 $5.29 Million
Q3 2019

Nov 14, 2019

BUY
$62.51 - $69.0 $406,627 - $448,845
6,505 Added 8.71%
81,154 $5.14 Million
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $4,949 - $5,550
80 Added 0.11%
74,649 $5.04 Million
Q1 2019

May 07, 2019

BUY
$62.53 - $70.05 $249,932 - $279,989
3,997 Added 5.66%
74,569 $4.85 Million
Q4 2018

Feb 11, 2019

SELL
$60.54 - $79.0 $2.17 Million - $2.83 Million
-35,807 Reduced 33.66%
70,572 $4.41 Million
Q3 2018

Nov 08, 2018

SELL
$71.28 - $78.92 $2.12 Million - $2.35 Million
-29,734 Reduced 21.85%
106,379 $8.21 Million
Q2 2018

Aug 03, 2018

BUY
$64.88 - $75.68 $1.23 Million - $1.43 Million
18,895 Added 16.12%
136,113 $9.64 Million
Q1 2018

May 09, 2018

BUY
$72.84 - $88.8 $27,315 - $33,300
375 Added 0.32%
117,218 $8.84 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $756,751 - $888,318
10,636 Added 10.01%
116,843 $8.37 Million
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $7.66 Million - $9.08 Million
106,207
106,207 $8.61 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.